Glenview Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NOV
NOV
|
+$394M |
| 2 |
WOOF
VCA Inc.
WOOF
|
+$236M |
| 3 |
Cadence Design Systems
CDNS
|
+$191M |
| 4 |
Herc Holdings
HRI
|
+$182M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$163M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LPNT
LifePoint Health, Inc.
LPNT
|
+$165M |
| 2 |
Fidelity National Information Services
FIS
|
+$153M |
| 3 |
American Tower
AMT
|
+$146M |
| 4 |
AET
Aetna Inc
AET
|
+$143M |
| 5 |
Electronic Arts
EA
|
+$140M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 34.05% |
| 2 | Consumer Discretionary | 11.57% |
| 3 | Technology | 9.93% |
| 4 | Financials | 7.77% |
| 5 | Industrials | 7.25% |
Similar funds
Glenview Capital Management's Q2 2014 Portfolio in Review
As of Q2 2014, Glenview Capital Management held 86 positions worth $17.3B, up 13% from $15.3B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Glenview Capital Management deployed $1.04B of net new capital in Q2 2014, opening 18 new positions and adding to 22 existing holdings. Its largest new stake was NOV: 5,292,631 shares worth $436M.
By sector, the portfolio is most concentrated in Healthcare at 34% of assets, down from 36% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was LifePoint Health, Inc., an estimated $165M trimmed.
- Glenview Capital Management's largest Q2 2014 buy was NOV: 5,292,631 shares worth $436M.
- Glenview Capital Management added most to VCA Inc. in Q2 2014, an estimated $236M increase.
- Glenview Capital Management's biggest Q2 2014 reduction was LifePoint Health, Inc., cutting an estimated $165M.
- Glenview Capital Management fully exited American Tower in Q2 2014, selling an estimated $146M.
- Glenview Capital Management's ten largest holdings make up 42% of its $17.3B portfolio in Q2 2014.
- Glenview Capital Management opened 18 new positions and closed 16 in Q2 2014.
- Glenview Capital Management's portfolio value rose 13% quarter-over-quarter to $17.3B.
Based on Glenview Capital Management's 13F filing for Q2 2014, filed 14 Aug 2014.